Tumor-Induced Hyperlipidemia Contributes to Tumor Growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-Induced Hyperlipidemia Contributes to Tumor Growth

Published:2016-04 Issue:2 Volume:15 Page:336-348
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Huang Jianfeng,Li Lena,Lian Jihong,Schauer Silvia,Vesely Paul W.,Kratky Dagmar,Hoefler Gerald,Lehner Richard

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference41 articles.

1. Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice;Ai;J. Clin. Invest.,2012

2. Tumor macroenvironment and metabolism;Al-Zoughbi;Semin. Oncol.,2014

3. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model;Alikhani;Oncogene,2013

4. Ceramide and ceramide 1-phosphate in health and disease;Arana;Lipids Health Dis.,2010

5. Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study;Benn;J. Natl. Cancer Inst.,2011

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers;Journal of Experimental & Clinical Cancer Research;2024-09-06

2. Integrating lipid metabolite analysis with MRI-based transformer and radiomics for early and late stage prediction of oral squamous cell carcinoma;BMC Cancer;2024-07-03

3. Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology;Biochemical Pharmacology;2024-05

4. Comprehensive analysis on clinical significance and therapeutic targets of LDL receptor related protein 11 (LRP11) in liver hepatocellular carcinoma;Frontiers in Pharmacology;2024-02-15

5. The Causal Relationship between PCSK9 Inhibitors and Malignant Tumors: A Mendelian Randomization Study Based on Drug Targeting;Genes;2024-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3